FDF03 Antibodies and uses thereof
AssigneeSchering Corporation
InventorsMichael E. Bigler, Drake M. LaFace, Kalyan Pande, Joseph H. Phillips
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for identifying and using modulators of FDF03 biological activity in vitro and in vivo that are useful in the treatment of cancer.
Claims18
A method for inhibiting tumor growth in a subject, comprising administering to a subject in need thereof an agent that stimulates or enhances FDF03 inhibitory receptor biological activity.
A method for reducing metastatic burden in a subject comprising administering to a subject in need thereof an agent that stimulates or enhances FDF03 inhibitory receptor biological activity.
A method for inhibiting tumor growth in a subject, comprising administering to a subject in need thereof an agent that binds to an FDF03 inhibiting receptor and an FDF03 activating receptor.
A method for reducing metastatic burden, comprising administering to a subject in need thereof an agent that binds to an FDF03 inhibiting receptor and an FDF03 activating receptor.
Dependencies are inferred from the claim text.